Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Common Equity (2016 - 2025)

InspireMD's Common Equity history spans 16 years, with the latest figure at $55.2 million for Q4 2025.

  • For Q4 2025, Common Equity rose 52.97% year-over-year to $55.2 million; the TTM value through Dec 2025 reached $55.2 million, up 52.97%, while the annual FY2025 figure was $55.2 million, 52.97% up from the prior year.
  • Common Equity reached $55.2 million in Q4 2025 per NSPR's latest filing, down from $64.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $64.1 million in Q3 2025 to a low of $13.4 million in Q1 2023.
  • Average Common Equity over 5 years is $36.0 million, with a median of $36.6 million recorded in 2021.
  • Peak YoY movement for Common Equity: soared 1164.14% in 2021, then crashed 56.71% in 2025.
  • A 5-year view of Common Equity shows it stood at $33.5 million in 2021, then tumbled by 48.13% to $17.4 million in 2022, then surged by 127.11% to $39.5 million in 2023, then dropped by 8.65% to $36.1 million in 2024, then skyrocketed by 52.97% to $55.2 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Common Equity are $55.2 million (Q4 2025), $64.1 million (Q3 2025), and $20.2 million (Q2 2025).